Angiogenesis is crucial in the progression of a number of pathological conditions, such as diabetic retinopathy, rheumatoid arthritis, psoriasis, and cancer [1] . In contrast to vessels in healthy tissues, the vasculature in these pathologies is highly unstable, constantly dissolving and renewing. Characteristically, vessels in pathologies have discontinuous basement membrane (BM) coverage [2] . The consequences of shifts in BM density and composition are still relatively unknown. As discussed below, several studies have illustrated that partial loss of the vascular BM during development results in the widening of vessels. This has been suggested to be a result of reduced mechanical resistance to the force inflicted by the blood pressure. However, recent data indicate that depletion of BM laminins (LMs) leads to enlarged vessels even in the absence of cardiac activity and blood pressure [3] .
functional compensation by related proteins. Deletion of the LMγ1-chain (lamc1-/-) in mice is incompatible with development beyond embryonic day 5.5, i.e., before onset of vascular development. However, in cultures of lamc1-/-embryoid bodies, vascular development proceeded. Analysis of the vascular BM revealed a total absence of extracellular LMs (13 out of 16 LM isoforms analyzed) [3] , similar to what has been demonstrated for lamc1-/-epithelial BM [10] . Still, ECs formed and organized into three-dimensional vascular structures with apparently normal pericyte coverage. Interestingly, the prominent vascular phenotype in lamc1-/-embryoid bodies was widened vessel lumen (see Fig. 1 for a schematic illustration). Thus, widening of the vascular lumen is a common phenotype to deletion of the vascular BM LMs. Since there is no flow in embryoid bodies, we conclude that widening of the vessel lumen in the absence of LM deposition is not a consequence of decreased resistance to shear stress or blood pressure in this model. What causes the widening of the vessel lumen in the absence of LMs? We could show that LM deficiency was accompanied by an increase in fibronectin and a decrease in collagen IV protein levels in the BM in the lamc1-/-embryoid bodies. It is possible that endothelial integrins become differentially activated as a consequence of this change in BM composition. Fibronectin is known to affect cellular morphology via its binding to β1 integrins. In accordance, lamc1-/-ECs were more spread out than wild-type ECs and, strikingly, the lamc1-/-phenotype was partially rescued by addition of purified LM protein. Also, lamc1-/-ECs sprouting into a surrounding collagen I matrix showed a higher rate of proliferation, which may reflect different integrin engagement. Since wide and thin vessels normally have roughly the same EC density (number of ECs/circumference), it is tempting to speculate that the degree of EC proliferation dictates the vessel diameter. It is unclear, however, whether an increased EC proliferative index would correlate with the final vessel diameter in vivo.
Apart from the EC proliferative index, migratory properties and differentiation cues in the microenvironment contribute to the width of a developing vessel. Mice exclusively expressing the diffusible vascular endothelial growth factor-A120 isoform display enlarged vessels in the developing hindbrain with increased numbers of ECs/vessel length [11] . Furthermore, induced overexpression of activated Notch4 gives rise to wider vessels both in embryoid bodies and in vivo, even though EC proliferation is reduced [12] . Also, the Notch ligand jagged 1 is up-regulated in the presence of LM-111 during differentiation of bovine ECs, suggesting a link between the two molecular systems [13] .
It is evident from the embryonic stem cell model, as well as from gene-targeted mouse models, that the vascular BM LMs play a role in establishment of the vessel architecture. However, LMs are not required for development of ECs per se [3] . Here we suggest that the balance of BM components plays an important role in regulation of EC proliferation and possibly other EC responses, which in turn dictates the vessel diameter. The vascular LMs may, therefore, in addition to serving as a scaffold and promoting cell attachment to avoid apoptosis, serve to control differentiation and restrict EC proliferation.
LM loss of function (LOF) studies have generated valuable in vivo data, but the knowledge is still incomplete. Detailed analysis of angiogenic tissues in the LM LOF mice may provide key information that is currently lacking. Furthermore, inducible LM LOFs would allow for analysis of the role of LMs in adult and pathological tissues. A key question is whether single BM components or fragments thereof play distinct roles in the angiogenic process, or if it is the balance between the different components of the BM that guides the morphology of the new vessel.
